{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:17:36Z","timestamp":1720934256758},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/mca.0000000000000375","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:06:31Z","timestamp":1461330391000},"page":"405-411","source":"Crossref","is-referenced-by-count":4,"title":["Intensive statin therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery disease treated with an everolimus-eluting stent"],"prefix":"10.1097","volume":"27","author":[{"given":"Hiroaki","family":"Sukegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210204","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells","volume":"23","author":"Dichtl","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-10-20210204","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"R3-10-20210204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"R4-10-20210204","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20080581","article-title":"Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications","volume":"117","author":"Niu","year":"2009","journal-title":"Clin Sci (Lond"},{"key":"R5-10-20210204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/jlb.67.4.471","article-title":"The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation","volume":"67","author":"Brandt","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R6-10-20210204","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1160\/TH07-04-0271","article-title":"Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl\/6 and apoE-\/- mice","volume":"98","author":"Sachais","year":"2007","journal-title":"Thromb Haemost"},{"key":"R7-10-20210204","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/187152811796117744","article-title":"Pentraxins: CRP and PTX3 and cardiovascular disease","volume":"10","author":"Maekawa","year":"2011","journal-title":"Inflamm Allergy Drug Targets"},{"key":"R8-10-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1684\/ecn.2014.0354","article-title":"Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation","volume":"25","author":"Hudzik","year":"2014","journal-title":"Eur Cytokine Netw"},{"key":"R9-10-20210204","doi-asserted-by":"crossref","first-page":"e0120633","DOI":"10.1371\/journal.pone.0120633","article-title":"Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease","volume":"10","author":"Ding","year":"2015","journal-title":"PLoS One"},{"key":"R10-10-20210204","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1753425914526461","article-title":"CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo","volume":"21","author":"Erbel","year":"2015","journal-title":"Innate Immun"},{"key":"R11-10-20210204","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/oxfordjournals.eurheartj.a062587","article-title":"Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4","volume":"9","author":"De Caterina","year":"1988","journal-title":"Eur Heart J"},{"key":"R12-10-20210204","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.64.3.626","article-title":"Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion","volume":"64","author":"Levine","year":"1981","journal-title":"Circulation"},{"key":"R13-10-20210204","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/0003319711403733","article-title":"Outcomes of intravascular ultrasound-guided percutaneous coronary intervention with drug-eluting stents versus bare metal stents for acute coronary syndrome in octogenarians","volume":"62","author":"Maekawa","year":"2011","journal-title":"Angiology"},{"key":"R14-10-20210204","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jacc.2013.03.086","article-title":"Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention","volume":"62","author":"Ohno","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R15-10-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"R16-10-20210204","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med"},{"key":"R17-10-20210204","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2010.06.045","article-title":"The evolving role of inflammatory biomarkers in risk assessment after stent implantation","volume":"56","author":"Niccoli","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R18-10-20210204","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1253\/circj.CJ-09-0358","article-title":"Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)","volume":"73","author":"Takayama","year":"2009","journal-title":"Circ J"},{"key":"R19-10-20210204","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/ATVBAHA.114.303932","article-title":"Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin","volume":"34","author":"Puri","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-10-20210204","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.105.585703","article-title":"Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial","volume":"113","author":"Schoenhagen","year":"2006","journal-title":"Circulation"},{"key":"R21-10-20210204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","article-title":"Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)","volume":"54","author":"Hiro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R22-10-20210204","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/hrt.2009.174912","article-title":"Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies","volume":"96","author":"He","year":"2010","journal-title":"Heart"},{"key":"R23-10-20210204","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-10-20210204","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cjca.2012.05.012","article-title":"The important role of inflammatory biomarkers pre and post bare-metal and drug-eluting stent implantation","volume":"28","author":"Khouzam","year":"2012","journal-title":"Can J Cardiol"},{"key":"R25-10-20210204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2008.03.058","article-title":"The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: the role of inflammation","volume":"136","author":"Celik","year":"2009","journal-title":"Int J Cardiol"},{"key":"R26-10-20210204","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.ATV.0000253884.13901.e4","article-title":"Implications of early structural-functional changes in the endothelium for vascular disease","volume":"27","author":"Simionescu","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R27-10-20210204","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis","volume":"44","author":"Deo","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R28-10-20210204","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.atherosclerosis.2005.03.007","article-title":"Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study","volume":"183","author":"Hoogeveen","year":"2005","journal-title":"Atherosclerosis"},{"key":"R29-10-20210204","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH03-02-0069","article-title":"Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters","volume":"90","author":"Pitsilos","year":"2003","journal-title":"Thromb Haemost"},{"key":"R30-10-20210204","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.2314","article-title":"Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions","volume":"215","author":"Savchenko","year":"2008","journal-title":"J Pathol"},{"key":"R31-10-20210204","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.ATV.0000015595.95497.2F","article-title":"Production of the long pentraxin PTX3 in advanced atherosclerotic plaques","volume":"22","author":"Rolph","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:38Z","timestamp":1620960038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201608000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000375","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}